Standard Financial Statements From 2010 to 2026

Standard Biotools' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time.We have found one hundred twenty available fundamental trend indicators for Standard Biotools, which can be analyzed and compared to other ratios and to its competition. All investors should make sure to check all of Standard Biotools' current market performance against the performance between 2010 and 2026 to make sure the company can sustain itself for the next two years. As of now, The current year's Market Cap is projected to rise to approximately 478.1 M, whereas Enterprise Value is moving lower toward about 274.1 M.Currently, Total Revenue is projected to increase significantly based on multi-year reporting trends. In the prior fiscal year, Total Revenue was reported at 85.33 Million. Currently, Gross Profit is projected to increase significantly based on multi-year reporting trends. In the prior fiscal year, Gross Profit was reported at 42.54 Million. As of now, The current year's Gross Profit Margin is projected to rise to 0.62, whereas Pretax Profit Margin is moving lower toward -1.19 .

Standard Biotools Total Revenue

91.02 Million

Review Standard Biotools Correlation against competitors for Standard Biotools. This adds peer-relative context.For information on how to trade Standard Stock refer to our How to Trade Standard Stock guide.